Information regarding discounts for Nayzilam is not readily available in the provided text.
What is Nayzilam?
Nayzilam (midazolam) nasal spray is a medication used to treat acute, repetitive, or seizure clusters in individuals 12 years of age and older [1]. It is a benzodiazepine that works by slowing down the brain and nervous system [1].
How is Nayzilam administered?
Nayzilam is administered as a single spray into one nostril [1]. It is intended for use by a caregiver or other person who is not experiencing the seizure [1].
What are the potential side effects of Nayzilam?
Common side effects of Nayzilam can include drowsiness, dizziness, nasal discomfort, and changes in taste [1]. Serious side effects may involve breathing problems, depression, and dependence [1].
When does Nayzilam's patent expire?
DrugPatentWatch.com tracks patent expiry dates for medications. Information on Nayzilam's specific patent expiration would be available through their services [2].
Who makes Nayzilam?
Nayzilam is manufactured by UCB Pharma [1].
How does Nayzilam compare to other seizure treatments?
Nayzilam is a rescue medication for acute seizure events, differing from daily maintenance seizure medications. Its nasal spray formulation offers a rapid route of administration for home use by a caregiver [1].
What is the typical cost of Nayzilam?
The cost of Nayzilam can vary significantly based on insurance coverage, pharmacy, and dosage. Specific pricing information is best obtained from pharmacies or through patient assistance programs [1].
Are there patient assistance programs for Nayzilam?
Pharmaceutical companies often offer patient assistance programs for their medications. Details on programs for Nayzilam can typically be found on the manufacturer's website or by contacting them directly [1].
Sources
1. https://www.nayzilam.com/
2. https://drugpatentwatch.com/